The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tumor Radiofrequency Ablation Market Research Report 2025
Synopsis
Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.
The global Tumor Radiofrequency Ablation market was valued at US$ 1482 million in 2023 and is anticipated to reach US$ 3629.9 million by 2030, witnessing a CAGR of 13.6% during the forecast period 2024-2030.
A significant driver in the Tumor Radiofrequency Ablation market is the growing demand for minimally invasive and localized treatment options for various types of tumors, including liver, kidney, and lung tumors. Radiofrequency ablation offers a precise and effective approach to destroy cancerous tissue while minimizing damage to surrounding healthy tissue. However, a notable challenge in this market is the need for patient selection and treatment optimization. Ensuring that radiofrequency ablation procedures are tailored to individual patient needs and that optimal treatment parameters are established while addressing potential complications or tumor recurrence poses a significant challenge. Healthcare providers and manufacturers must focus on patient assessment, ongoing monitoring, and technological advancements to refine radiofrequency ablation therapies and improve patient outcomes in the battle against cancer.
This report aims to provide a comprehensive presentation of the global market for Tumor Radiofrequency Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Radiofrequency Ablation.
Report Scope
The Tumor Radiofrequency Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Radiofrequency Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Radiofrequency Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical
Segment by Type
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Others
Segment by Application
Hospitals
Cancer Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Radiofrequency Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.
The global Tumor Radiofrequency Ablation market was valued at US$ 1482 million in 2023 and is anticipated to reach US$ 3629.9 million by 2030, witnessing a CAGR of 13.6% during the forecast period 2024-2030.
A significant driver in the Tumor Radiofrequency Ablation market is the growing demand for minimally invasive and localized treatment options for various types of tumors, including liver, kidney, and lung tumors. Radiofrequency ablation offers a precise and effective approach to destroy cancerous tissue while minimizing damage to surrounding healthy tissue. However, a notable challenge in this market is the need for patient selection and treatment optimization. Ensuring that radiofrequency ablation procedures are tailored to individual patient needs and that optimal treatment parameters are established while addressing potential complications or tumor recurrence poses a significant challenge. Healthcare providers and manufacturers must focus on patient assessment, ongoing monitoring, and technological advancements to refine radiofrequency ablation therapies and improve patient outcomes in the battle against cancer.
This report aims to provide a comprehensive presentation of the global market for Tumor Radiofrequency Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Radiofrequency Ablation.
Report Scope
The Tumor Radiofrequency Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Radiofrequency Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Radiofrequency Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical
Segment by Type
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Others
Segment by Application
Hospitals
Cancer Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Radiofrequency Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Radiofrequency Ablation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lung Cancer
1.2.3 Kidney Cancer
1.2.4 Breast Cancer
1.2.5 Prostate Cancer
1.2.6 Liver Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tumor Radiofrequency Ablation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Cancer Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Radiofrequency Ablation Market Perspective (2019-2030)
2.2 Tumor Radiofrequency Ablation Growth Trends by Region
2.2.1 Global Tumor Radiofrequency Ablation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Radiofrequency Ablation Historic Market Size by Region (2019-2024)
2.2.3 Tumor Radiofrequency Ablation Forecasted Market Size by Region (2025-2030)
2.3 Tumor Radiofrequency Ablation Market Dynamics
2.3.1 Tumor Radiofrequency Ablation Industry Trends
2.3.2 Tumor Radiofrequency Ablation Market Drivers
2.3.3 Tumor Radiofrequency Ablation Market Challenges
2.3.4 Tumor Radiofrequency Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Radiofrequency Ablation Players by Revenue
3.1.1 Global Top Tumor Radiofrequency Ablation Players by Revenue (2019-2024)
3.1.2 Global Tumor Radiofrequency Ablation Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Radiofrequency Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Radiofrequency Ablation Revenue
3.4 Global Tumor Radiofrequency Ablation Market Concentration Ratio
3.4.1 Global Tumor Radiofrequency Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Radiofrequency Ablation Revenue in 2023
3.5 Tumor Radiofrequency Ablation Key Players Head office and Area Served
3.6 Key Players Tumor Radiofrequency Ablation Product Solution and Service
3.7 Date of Enter into Tumor Radiofrequency Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Radiofrequency Ablation Breakdown Data by Type
4.1 Global Tumor Radiofrequency Ablation Historic Market Size by Type (2019-2024)
4.2 Global Tumor Radiofrequency Ablation Forecasted Market Size by Type (2025-2030)
5 Tumor Radiofrequency Ablation Breakdown Data by Application
5.1 Global Tumor Radiofrequency Ablation Historic Market Size by Application (2019-2024)
5.2 Global Tumor Radiofrequency Ablation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Radiofrequency Ablation Market Size (2019-2030)
6.2 North America Tumor Radiofrequency Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Radiofrequency Ablation Market Size by Country (2019-2024)
6.4 North America Tumor Radiofrequency Ablation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Radiofrequency Ablation Market Size (2019-2030)
7.2 Europe Tumor Radiofrequency Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Radiofrequency Ablation Market Size by Country (2019-2024)
7.4 Europe Tumor Radiofrequency Ablation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size (2019-2030)
8.2 Asia-Pacific Tumor Radiofrequency Ablation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Radiofrequency Ablation Market Size (2019-2030)
9.2 Latin America Tumor Radiofrequency Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Radiofrequency Ablation Market Size by Country (2019-2024)
9.4 Latin America Tumor Radiofrequency Ablation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Radiofrequency Ablation Market Size (2019-2030)
10.2 Middle East & Africa Tumor Radiofrequency Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Detail
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Tumor Radiofrequency Ablation Introduction
11.1.4 Boston Scientific Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.1.5 Boston Scientific Recent Development
11.2 Diros Technology
11.2.1 Diros Technology Company Detail
11.2.2 Diros Technology Business Overview
11.2.3 Diros Technology Tumor Radiofrequency Ablation Introduction
11.2.4 Diros Technology Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.2.5 Diros Technology Recent Development
11.3 Halyard Health
11.3.1 Halyard Health Company Detail
11.3.2 Halyard Health Business Overview
11.3.3 Halyard Health Tumor Radiofrequency Ablation Introduction
11.3.4 Halyard Health Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.3.5 Halyard Health Recent Development
11.4 St. Jude Medical
11.4.1 St. Jude Medical Company Detail
11.4.2 St. Jude Medical Business Overview
11.4.3 St. Jude Medical Tumor Radiofrequency Ablation Introduction
11.4.4 St. Jude Medical Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.4.5 St. Jude Medical Recent Development
11.5 Cosman Medical
11.5.1 Cosman Medical Company Detail
11.5.2 Cosman Medical Business Overview
11.5.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
11.5.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.5.5 Cosman Medical Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Tumor Radiofrequency Ablation Introduction
11.6.4 Medtronic Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 NeuroTherm
11.7.1 NeuroTherm Company Detail
11.7.2 NeuroTherm Business Overview
11.7.3 NeuroTherm Tumor Radiofrequency Ablation Introduction
11.7.4 NeuroTherm Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.7.5 NeuroTherm Recent Development
11.8 Stryker
11.8.1 Stryker Company Detail
11.8.2 Stryker Business Overview
11.8.3 Stryker Tumor Radiofrequency Ablation Introduction
11.8.4 Stryker Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.8.5 Stryker Recent Development
11.9 Cosman Medical
11.9.1 Cosman Medical Company Detail
11.9.2 Cosman Medical Business Overview
11.9.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
11.9.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2019-2024)
11.9.5 Cosman Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
